Q3 2024 Coherus BioSciences Inc Earnings Call

In This Article:

Participants

Jodi Sievers; Vice President, Corporate Communications; Coherus BioSciences Inc

Dennis Lanfear; Chairman of the Board, President, Chief Executive Officer; Coherus BioSciences Inc

Paul Reider; Chief Commercial Officer; Coherus BioSciences Inc

Theresa Lavallee; Chief Development Officer; Coherus BioSciences Inc

Rosh Dias; Chief Medical Officer; Coherus BioSciences Inc

Bryan Mcmichael; Chief Financial Officer; Coherus BioSciences Inc

Alex Xenakis; Analyst; Truist Securities

Unidentified Participant

Michael Nedelcovych; Analyst; TD Cowen

Douglas Tsao; Analyst; H.C. Wainwright & Co., LLC

Brian Chen; Analyst; JPMorgan

Presentation

Operator

Good day. And thank you for standing by. Welcome to the Q3 2024 Coherus BioSciences earnings conference call. (Operator Instructions)
Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your speaker today, Jodi Sievers, Head of Investor Relations. Please go ahead.

Jodi Sievers

Thank you, Daniel. Good afternoon and welcome to Coherus BioSciences third-quarter 2024 earnings conference call. Joining me today to discuss our results are Denny Lanfear, Chief Executive Officer of Coherus, Bryan McMichael, Chief Financial Officer; Paul Reider, Chief Commercial Officer; Dr. Rosh Dias, Chief Medical Officer; and Dr. Theresa Lavallee, Chief Development Officer.
Before we get started, I'd like to remind you that today's call includes forward-looking statements regarding Coherus' current expectations about future events. These statements include but are not limited to the following: expectations for the time that it will take for labeling and packaging CMO to resume packaging of UDENYCA and projections about the timing and number of units that it will complete; projections about the timing and number of units that may be completed by our additional labeling and packaging CMO; and projections about future revenues, market share and expenses.
All of these forward-looking statements involve substantial risks and uncertainties that are beyond our control and could cause actual results, performance, or achievements to differ from those implied by the forward-looking statements. These statements are not guarantees of future performance and are subject to substantial risks and uncertainties including risks and uncertainties inherent in our manufacturing process and our reliance on third parties that are discussed in our press release that we issued today, as well as the documents that we file with the SEC. Forward-looking statements provided on the call today are made as of this state and we undertake no duty to update or revise any forward-looking statement.
And now I'll turn the call over to Denny.

Waiting for permission
Allow microphone access to enable voice search

Try again.